Login

Decibel Therapeutics, Inc. SEC Filings

Filed On Filing
14 Feb 2024 SC 13G/A
10 Oct 2023 15-12G
06 Oct 2023 EFFECT
27 Sep 2023 SC 13D/A
25 Sep 2023 Form 4: Trask Anna, Chief People Officer

Returned 106,864 shares to the issuer · Disposed of 234,802 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Carson William H., Director

Returned 5,000 shares to the issuer · Disposed of 35,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Lee John Jui-Jen, Chief Development Officer

Returned 147,144 shares to the issuer · Disposed of 329,503 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Finger Alison Cecily, Director

Returned 5,000 shares to the issuer · Disposed of 35,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Mclaughlin Kevin F, Director

Returned 5,000 shares to the issuer · Disposed of 25,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Reid Laurence, Director

Returned 220,849 shares to the issuer · Disposed of 1,332,039 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Kapusta Matthew C, Director

Returned 10,000 shares to the issuer · Disposed of 10,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 Form 4: Nochur Sara, Director

Returned 5,000 shares to the issuer · Disposed of 35,000 Stock Option (right to buy) (Disposition to Issuer)

25 Sep 2023 S-8 POS
25 Sep 2023 S-8 POS
25 Sep 2023 S-8 POS
25 Sep 2023 POS AM
25 Sep 2023 SC 14D9/A
25 Sep 2023 25-NSE
25 Sep 2023 SC TO-T/A
25 Sep 2023 8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support